Valneva SE announced the earnings guidance for 2024. For the year Product sales expected between ?150 million and ?180 million, reflecting continued revenue growth for proprietary products and IXCHIQ®?s launch-year sales, despite anticipated supply constraints for third-party products and IXIARO®.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.364 EUR | +3.32% | -2.04% | -28.73% |
May. 07 | Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.73% | 503M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva Se Announces Earnings Guidance for 2024